These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 39120974)

  • 21. Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair.
    Kausar T; Schreiber JS; Karnak D; Parsels LA; Parsels JD; Davis MA; Zhao L; Maybaum J; Lawrence TS; Morgan MA
    Neoplasia; 2015 Oct; 17(10):757-66. PubMed ID: 26585231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia.
    Garcia TB; Uluisik RC; van Linden AA; Jones KL; Venkataraman S; Vibhakar R; Porter CC
    Front Oncol; 2020; 10():296. PubMed ID: 32195191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer.
    Jhuraney A; Woods NT; Wright G; Rix L; Kinose F; Kroeger JL; Remily-Wood E; Cress WD; Koomen JM; Brantley SG; Gray JE; Haura EB; Rix U; Monteiro AN
    Mol Cancer Ther; 2016 Jul; 15(7):1669-81. PubMed ID: 27196765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.
    Chen X; Low KH; Alexander A; Jiang Y; Karakas C; Hess KR; Carey JPW; Bui TN; Vijayaraghavan S; Evans KW; Yi M; Ellis DC; Cheung KL; Ellis IO; Fu S; Meric-Bernstam F; Hunt KK; Keyomarsi K
    Clin Cancer Res; 2018 Dec; 24(24):6594-6610. PubMed ID: 30181387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage.
    de Jong MRW; Langendonk M; Reitsma B; Herbers P; Nijland M; Huls G; van den Berg A; Ammatuna E; Visser L; van Meerten T
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31703356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of DNA replication stress marked by high-intensity, pan-nuclear γH2AX staining to chemosensitization by CHK1 and WEE1 inhibitors.
    Parsels LA; Parsels JD; Tanska DM; Maybaum J; Lawrence TS; Morgan MA
    Cell Cycle; 2018; 17(9):1076-1086. PubMed ID: 29895190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis.
    Fang B; Kannan A; Guo T; Gao L
    Int J Biol Sci; 2018; 14(10):1221-1231. PubMed ID: 30123071
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors.
    Fallah Y; Demas DM; Jin L; He W; Shajahan-Haq AN
    Front Oncol; 2021; 11():681530. PubMed ID: 34277427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer.
    Xiao R; You L; Zhang L; Guo X; Guo E; Zhao F; Yang B; Li X; Fu Y; Lu F; Wang Z; Liu C; Peng W; Li W; Yang X; Dou Y; Liu J; Wang W; Qin T; Cui Y; Zhang X; Li F; Jin Y; Zeng Q; Wang B; Mills GB; Chen G; Sheng X; Sun C
    Adv Sci (Weinh); 2022 Jul; 9(21):e2105469. PubMed ID: 35619328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer.
    Wang Q; Chao Y; Chen Y; Zheng W; Demanelis K; Liu Y; Connelly J; Wang H
    Res Sq; 2023 Nov; ():. PubMed ID: 37987002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers.
    Hu Z; Viswanathan R; Cheng H; Chen J; Yang X; Huynh A; Clavijo P; An Y; Robbins Y; Silvin C; Allen C; Ormanoglu P; Martin S; Cornelius S; Saleh A; Chen Z; Van Waes C; Morgan EL
    Mol Cancer Res; 2022 Jun; 20(6):867-882. PubMed ID: 35176168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.
    Mancini M; De Santis S; Monaldi C; Castagnetti F; Lonetti A; Bruno S; Dan E; Sinigaglia B; Rosti G; Cavo M; Gugliotta G; Soverini S
    Front Oncol; 2022; 12():901132. PubMed ID: 35992847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation.
    Wang B; Sun L; Yuan Z; Tao Z
    Med Oncol; 2020 Jul; 37(8):66. PubMed ID: 32696094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Characterization of a Wee1 Kinase Degrader.
    Li Z; Pinch BJ; Olson CM; Donovan KA; Nowak RP; Mills CE; Scott DA; Doctor ZM; Eleuteri NA; Chung M; Sorger PK; Fischer ES; Gray NS
    Cell Chem Biol; 2020 Jan; 27(1):57-65.e9. PubMed ID: 31735695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma.
    Hu Z; Li L; Lan W; Wei X; Wen X; Wu P; Zhang X; Xi X; Li Y; Wu L; Li W; Liao X
    Cancer Res Treat; 2022 Jan; 54(1):277-293. PubMed ID: 33971703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
    Moreira DC; Venkataraman S; Subramanian A; Desisto J; Balakrishnan I; Prince E; Pierce A; Griesinger A; Green A; Eberhardt CG; Foreman NK; Vibhakar R
    J Neurooncol; 2020 May; 147(3):531-545. PubMed ID: 32180106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.
    Fukuda K; Takeuchi S; Arai S; Nanjo S; Sato S; Kotani H; Kita K; Nishiyama A; Sakaguchi H; Ohtsubo K; Yano S
    Cell Rep Med; 2024 Jun; 5(6):101578. PubMed ID: 38776912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.
    Garcia TB; Fosmire SP; Porter CC
    Leuk Res; 2018 Jan; 64():30-33. PubMed ID: 29175378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer.
    Liu D; Cao Z; Xu W; Lin G; Zhou X; Ding X; Wang N; Wu C; Su B
    Biomed Pharmacother; 2019 Sep; 117():109185. PubMed ID: 31387179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of
    Liang J; Zhao H; Diplas BH; Liu S; Liu J; Wang D; Lu Y; Zhu Q; Wu J; Wang W; Yan H; Zeng YX; Wang X; Jiao Y
    Cancer Res; 2020 Feb; 80(3):510-523. PubMed ID: 31551363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.